Virtual Library

Start Your Search

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

Filter Results:

Show Only Available Presentations

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • Presentations: 108
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP08.01-090 - Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront.

      Author(s): Javier Torres Jiménez

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP08.01-091 - Association of dNLR Score with Outcomes in Patients with Advanced NSCLC Under Immunotherapy Alone +/- Chemotherapy Upfront

      Author(s): Teresa Gorria

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • Presentations: 171
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP08.02-041 - NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study

      Author(s): Alexander Drilon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP08.02-016 - Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs

      Author(s): Nicolas Girard

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP08.02-173 - Treatment Patterns and Outcomes Among Patients With EGFR-mutant Advanced NSCLC in the Frontline and Post-Osimertinib Settings

      Author(s): Joshua Sabari

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance

    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • Presentations: 9
    • Moderators:Benjamin Besse
    • Coordinates: 8/07/2022, 12:00 - 13:00, Strauss 1/2
    • +

      ES07.01 - Session Introduction

      12:00 - 12:01  |  Author(s): Benjamin Besse

      • Abstract

      Loading...

    • +

      ES07.02 - Session Introduction

      12:01 - 12:02  |  Author(s): Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression

      12:02 - 12:14  |  Author(s): Trever Bivona

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)

      12:14 - 12:26  |  Author(s): Sandra Ortiz-Cuaran

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC

      12:26 - 12:38  |  Author(s): Triparna Sen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics

      12:38 - 12:50  |  Author(s): Helmut Popper

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES07.07 - Live Q&A

      12:50 - 13:00

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Session Moderator

      12:50 - 13:00  |  Author(s): Benjamin Besse

      • Abstract

      Loading...

    • +

      Session Moderator

      12:50 - 13:00  |  Author(s): Yuko Minami

      • Abstract

      Loading...

  • +

    P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • Type: Regular Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • Presentations: 4
    • Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
    • +

      P1.16-02 - Clinical Utility of ctDNA in Advanced NSCLC at Diagnosis or Where Insufficient Tissue Was Available, Based on the ESMO ESCAT Scale

      Author(s): Laura Mezquita

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)

    • Type: Plenary
    • Track: N/A
    • Presentations: 17
    • Moderators:Heather Wakelee
    • Coordinates: 8/08/2022, 08:30 - 10:20, Hall C1
  • +

    OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?

    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • Presentations: 10
    • +

      OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)

      11:32 - 11:42  |  Author(s): Edouard Auclin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA07 - Overcoming Resistance to EGFR Inhibitors

    • Type: Mini Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • Presentations: 13
    • +

      MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA

      12:42 - 12:47  |  Author(s): Laura Mezquita

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA10 - Updates in Thymoma

    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • Presentations: 13
    • Moderators:Noboru Yamamoto
    • Coordinates: 8/08/2022, 14:45 - 15:45, Hall C8
  • +

    OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco

    • Type: Oral
    • Track: Epidemiology
    • Presentations: 10
    • +

      OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study

      10:57 - 11:07  |  Author(s): Miguel Garcia Pardo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA15 - Patient Selection in Advanced NSCLC Immunotherapy

    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • Presentations: 10
    • Moderators:Pilar Garrido
    • Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
    • +

      OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

      14:52 - 15:02  |  Author(s): Benjamin Besse

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.